Intestinal microbiome as a novel therapeutic target for local and systemic inflammation.

Abstract:

:Recently, the pathogenesis of systemic inflammatory disease such as inflammatory bowel disease (IBD), multiple sclerosis (MS), systemic inflammatory arthritis, asthma, and non-alcoholic fatty liver disease has been reported to be related to the dysbiosis of gut microbiota. The contribution of special bacteria for the development of those diseases has been elucidated by disease animal models such as germ-free mice. Besides, the contribution by several bacteria for the pathogenesis of those diseases has been suggested by detailed analysis of the 16 small ribosomal subunit RNA (16S rRNA) from stool samples of the patients. Gut microbiota-targeted treatment for systemic inflammatory diseases such as fecal microbiota transplant (FMT), and probiotics has been now reported. Though there are several issues to be understood, these treatments have been highlighted as an innovative approach to intractable systemic inflammatory disease. In the present review, recent reports regarding the relation between gut microbiota and systemic inflammatory diseases are discussed with treatments to target gut microbiota.

journal_name

Pharmacol Ther

authors

Uchiyama K,Naito Y,Takagi T

doi

10.1016/j.pharmthera.2019.03.006

subject

Has Abstract

pub_date

2019-07-01 00:00:00

pages

164-172

eissn

0163-7258

issn

1879-016X

pii

S0163-7258(19)30045-2

journal_volume

199

pub_type

杂志文章,评审
  • Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness.

    abstract::Over the past 15 years, novel pharmacologic treatments for the management of HIV/AIDS and severe mental illness have changed the prognosis and quality of life for millions of patients throughout the world. In HIV-infected patients, highly active antiretroviral therapy (HAART) has altered this epidemic in many countrie...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2009.07.004

    authors: Vergara-Rodriguez P,Vibhakar S,Watts J

    更新日期:2009-12-01 00:00:00

  • Cocaine use disorder: A look at metabotropic glutamate receptors and glutamate transporters.

    abstract::Glutamate transmission is an important mediator of the development of substance use disorders, particularly with regard to relapse. The present review summarizes the changes in glutamate levels in the reward system (the prefrontal cortex, nucleus accumbens, dorsal striatum, hippocampus, and ventral tegmental area) obs...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2020.107797

    authors: Niedzielska-Andres E,Pomierny-Chamioło L,Andres M,Walczak M,Knackstedt LA,Filip M,Przegaliński E

    更新日期:2021-01-09 00:00:00

  • The role of amyloid beta peptide 42 in Alzheimer's disease.

    abstract::During the last 20 years, an expanding body of research has elucidated the central role of amyloid precursor protein (APP) processing and amyloid beta peptide (Abeta) production in the risk, onset, and progression of the neurodegenerative disorder Alzheimer's disease (AD), the most common form of dementia. Ongoing res...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2007.06.006

    authors: Findeis MA

    更新日期:2007-11-01 00:00:00

  • Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.

    abstract::Multiple sclerosis (MS) is the commonest cause of progressive neurological disability amongst young, Caucasian adults. MS is considered to be an auto-immune disease that results from an attack against myelin, the layer which surrounds axons. The pathophysiology of MS is complex, with both demyelination and axonal dege...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2010.01.006

    authors: Van der Walt A,Butzkueven H,Kolbe S,Marriott M,Alexandrou E,Gresle M,Egan G,Kilpatrick T

    更新日期:2010-04-01 00:00:00

  • Clues to asthma pathogenesis from microarray expression studies.

    abstract::Asthma is a chronic inflammatory disease characterized by airway hyperresponsiveness (AHR), tissue remodeling, and airflow obstruction. The pathogenesis of asthma is only partly understood, and there is an urgent need for improved therapeutic strategies for this disease. Microarray technology has considerable promise ...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2005.08.009

    authors: Rolph MS,Sisavanh M,Liu SM,Mackay CR

    更新日期:2006-01-01 00:00:00

  • Potential role of female sex hormones in the pathophysiology of migraine.

    abstract::Clinical evidence indicates that female sex steroids may contribute to the high prevalence of migraine in women, as well as changes in the frequency or severity of migraine attacks that are in tandem with various reproductive milestones in women's life. While female sex steroids do not seem to be involved in the patho...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2006.08.009

    authors: Gupta S,Mehrotra S,Villalón CM,Perusquía M,Saxena PR,MaassenVanDenBrink A

    更新日期:2007-02-01 00:00:00

  • Sensitization of adenylate cyclase by Galpha i/o-coupled receptors.

    abstract::Activation of receptors coupled to inhibitory G proteins (Galpha i/o) has opposing consequences for cyclic AMP accumulation and the activity of cyclic AMP-dependent protein kinase, depending on the duration of stimulation. Acute activation inhibits the activity of adenylate cyclase, thereby attenuating cyclic AMP accu...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2004.12.005

    authors: Watts VJ,Neve KA

    更新日期:2005-06-01 00:00:00

  • Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs.

    abstract::Several amphetamine analogs are potent psychostimulants and major drugs of abuse. In animal models, the psychomotor and reinforcing effects of amphetamine, methamphetamine (METH), 3,4-methylenedioxymethamphetamine (MDMA; Ecstasy), and methylphenidate (MPD; Ritalin) are thought to be dependent on increased extracellula...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2005.08.004

    authors: Itzhak Y,Ali SF

    更新日期:2006-01-01 00:00:00

  • The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement.

    abstract::The neurobiological processes by which ethanol seeking and consumption are established and maintained are thought to involve areas of the brain that mediate motivated behavior, such as the mesolimbic dopamine system. The mesolimbic dopamine system is comprised of cells that originate in the ventral tegmental area (VTA...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2004.06.002

    authors: Gonzales RA,Job MO,Doyon WM

    更新日期:2004-08-01 00:00:00

  • Antimicrobial peptides, nanotechnology, and natural metabolites as novel approaches for cancer treatment.

    abstract::Despite the advances in tumor identification and treatment, cancer remains the primary driver of death around the world. Also, regular treatments for the disease are incapable of targeting particular cancer types at different stages since they are not specifically focused on harmful cells since they influence both sol...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2017.10.010

    authors: Leite ML,da Cunha NB,Costa FF

    更新日期:2018-03-01 00:00:00

  • Pokeweed antiviral protein: ribosome inactivation and therapeutic applications.

    abstract::Pokeweed antiviral protein (PAP) is a ribosome-inactivating protein (RIP) that inactivates ribosomes by the removal of a single adenine from ribosomal RNA. The studies summarized in our review concern the nature and application of this novel therapeutic agent. We describe how researchers continue to elucidate the stru...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/0163-7258(92)90053-3

    authors: Irvin JD,Uckun FM

    更新日期:1992-01-01 00:00:00

  • A novel paradigm for therapeutic basis of advanced heart failure--assessment by gene therapy.

    abstract::The precise mechanism(s) of the progression of advanced heart failure (HF) should be determined to establish strategies for its treatment or prevention. Based on pathological, molecular, and physiological findings in 3 animal models and human cases, we propose a novel scheme that a vicious cycle formed by increased sa...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2004.12.006

    authors: Kawada T,Masui F,Kumagai H,Koshimizu M,Nakazawa M,Toyo-Oka T

    更新日期:2005-07-01 00:00:00

  • Allosteric pathways in nuclear receptors - Potential targets for drug design.

    abstract::The nuclear receptor family of transcription factor proteins mediates endocrine function and plays critical roles in the development, physiology and pharmacology. Malfunctioning nuclear receptors are associated with several disease states. The functional activity of nuclear receptors is regulated by small molecular ho...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2017.10.014

    authors: Fernandez EJ

    更新日期:2018-03-01 00:00:00

  • Oncogenic pathways that affect antitumor immune response and immune checkpoint blockade therapy.

    abstract::Mechanistic insights of cancer immunology have led to the development of immune checkpoint blockade therapy (ICBT), which has elicited a remarkable clinical response in some cancer patients. Increasing evidence suggests that activation of oncogenic pathways, such as RAS/RAF/MAPK and PI3K signaling, impairs the antitum...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2017.07.004

    authors: Zhao X,Subramanian S

    更新日期:2018-01-01 00:00:00

  • The pharmacology of bitter taste receptors and their role in human airways.

    abstract::The receptors involved in bitter taste perception (bitter taste receptors--T2Rs) constitute a family of G-protein-coupled receptors, of which around 29 subtypes have been identified in humans. T2R expression was initially thought to be confined to the oral cavity but has recently been described in a range of other tis...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2015.08.001

    authors: Devillier P,Naline E,Grassin-Delyle S

    更新日期:2015-11-01 00:00:00

  • Ross River virus: molecular and cellular aspects of disease pathogenesis.

    abstract::Ross River virus (RRV) is a mosquito-borne alphavirus indigenous to Australia and the Western Pacific region and is responsible for several thousand cases of human RRV disease (RRVD) per annum. The disease primarily involves polyarthritis/arthralgia, with many patients also presenting with rash, myalgia, fever, and/or...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2005.03.006

    authors: Rulli NE,Suhrbier A,Hueston L,Heise MT,Tupanceska D,Zaid A,Wilmes A,Gilmore K,Lidbury BA,Mahalingam S

    更新日期:2005-09-01 00:00:00

  • The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

    abstract::Methamphetamine (METH) abuse is a major public health issue around the world, yet there are currently no effective pharmacotherapies for the treatment of METH addiction. METH is a potent psychostimulant that increases extracellular dopamine levels by targeting the dopamine transporter (DAT) and alters neuronal activit...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2018.01.009

    authors: Sambo DO,Lebowitz JJ,Khoshbouei H

    更新日期:2018-06-01 00:00:00

  • New hope for cancer treatment: exploring the distinction between normal adult stem cells and cancer stem cells.

    abstract::For decades, intensive studies have attempted to identify the mechanisms underlying malignant tumor growth. Despite significant progress, most therapeutic approaches fail to eliminate all tumor cells. The remaining tumor cells often result in recurrence and metastasis. Recently, the idea of a cancer stem cell was prop...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2008.04.008

    authors: Zhao RC,Zhu YS,Shi Y

    更新日期:2008-07-01 00:00:00

  • Pathophysiological relevance of NO signaling in the cardiovascular system: novel insight from mice lacking all NO synthases.

    abstract::Nitric oxide (NO) exerts a variety of biological actions under both physiological and pathological conditions. NO is synthesized by three distinct NO synthase (NOS) isoforms, including neuronal (nNOS), inducible (iNOS), and endothelial NOS (eNOS), all of which are expressed in the human cardiovascular system. The role...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2010.08.010

    authors: Tsutsui M,Shimokawa H,Otsuji Y,Yanagihara N

    更新日期:2010-12-01 00:00:00

  • Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity.

    abstract::Cytotoxic drug-induced nausea and vomiting are the side effects most feared by cancer patients. Emesis is an instinctive defense reaction caused by the somatoautonomic nerve reflex, which is integrated in the medulla oblongata. Emesis caused by cytotoxic drugs such as cisplatin is associated with an increase in the co...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/s0163-7258(03)00057-3

    authors: Minami M,Endo T,Hirafuji M,Hamaue N,Liu Y,Hiroshige T,Nemoto M,Saito H,Yoshioka M

    更新日期:2003-08-01 00:00:00

  • O-GlcNAc and the cardiovascular system.

    abstract::The cardiovascular system is capable of robust changes in response to physiologic and pathologic stimuli through intricate signaling mechanisms. The area of metabolism has witnessed a veritable renaissance in the cardiovascular system. In particular, the post-translational β-O-linkage of N-acetylglucosamine (O-GlcNAc)...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2013.11.005

    authors: Dassanayaka S,Jones SP

    更新日期:2014-04-01 00:00:00

  • Cellular and molecular therapeutic modalities for arterial obstructive syndromes.

    abstract::Arterial obstructive syndromes result in heart disease, stroke and limb loss, disability, and mortality. Currently available therapeutics for patients with these conditions are inadequate or fail in a significant number of patients. The development of novel therapies for severe coronary arterial disease (CAD), periphe...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2005.08.005

    authors: Staudacher DL,Preis M,Lewis BS,Grossman PM,Flugelman MY

    更新日期:2006-01-01 00:00:00

  • VMAT2 inhibitors for the treatment of hyperkinetic movement disorders.

    abstract::Hyperkinetic movement disorders comprise a variety of conditions characterized by involuntary movements, which include but are not limited to tardive dyskinesia, chorea associated with Huntington's Disease, and tic disorders. The class of medications that have been used to treat these conditions includes Vesicular Mon...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2020.107580

    authors: Koch J,Shi WX,Dashtipour K

    更新日期:2020-08-01 00:00:00

  • Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.

    abstract::Alcoholism is a chronic relapsing disorder. Major characteristics observed in alcoholics during an initial period of alcohol abstinence are altered physiological functions and a negative emotional state. Evidence suggests that a persistent, cumulative adaptation involving a kindling/allostasis-like process occurs duri...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2010.09.007

    authors: Breese GR,Sinha R,Heilig M

    更新日期:2011-02-01 00:00:00

  • Studies on anti-human immunodeficiency virus oligonucleotides that have alternating methylphosphonate/phosphodiester linkages.

    abstract::Preliminary investigations of the physical properties of oligonucleotide analogs that contain alternating methylphosphonate/phosphodiester linkages are described. An alternating oligo-2'-O-methylribonucleoside methylphosphonate, oligomer 1676, whose sequence is complementary to the upper hairpin region of human immuno...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/s0163-7258(99)00054-6

    authors: Miller PS,Cassidy RA,Hamma T,Kondo NS

    更新日期:2000-03-01 00:00:00

  • Potassium channel activation: a potential therapeutic approach?

    abstract::The physiological role of K+ channel opening by endogenous substances (e.g., neurotransmitters and hormones) is a recognised inhibitory mechanism. Thus, the identification of novel synthetic molecules that 'directly' open K+ channels has led to a new direction in the pharmacology of ion channels. The existence of many...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/0163-7258(96)00003-4

    authors: Lawson K

    更新日期:1996-01-01 00:00:00

  • Beta-N-acetylhexosaminidase: a target for the design of antifungal agents.

    abstract::This review provides biochemical, analytical, and biological background information relating to beta-N-acetylhexosaminidase (HexNAc'ase; EC 3.2.1.52) as an emerging target for the design of low-molecular-weight antifungals. The article includes the following: (1) a biochemical description of HexNAc'ase (reaction catal...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/s0163-7258(97)00110-1

    authors: Horsch M,Mayer C,Sennhauser U,Rast DM

    更新日期:1997-10-01 00:00:00

  • Astroglial neurotrophic and neurite-promoting factors.

    abstract::Astroglial cells express neurotrophic and/or neurite growth-promoting factors, including (a) peptide growth factors (e.g. nerve growth factors, ciliary neuronotrophic factor, fibroblast growth factor), (b) neurotransmitters (such as glutamate, neuropeptide Y), (c) cell adhesion molecules (e.g. N-CAM) and (d) extracell...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/0163-7258(94)00047-7

    authors: Müller HW,Junghans U,Kappler J

    更新日期:1995-01-01 00:00:00

  • Role of pharmacotherapy in cardiac ion channelopathies.

    abstract::In the last decade, there have been considerable advances in the understanding of the pathophysiology of malignant ventricular tachyarrhythmias (VT) and sudden cardiac death (SCD). Over 80% of SCD occurs in patients with organic heart disease. However, approximately 10%-15% of SCD occurs in the presence of structurall...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2015.09.002

    authors: El-Sherif N,Boutjdir M

    更新日期:2015-11-01 00:00:00

  • Matrix reloaded: CCN, tenascin and SIBLING group of matricellular proteins in orchestrating cancer hallmark capabilities.

    abstract::Matricellular proteins (MCPs) are the non-structural extracellular matrix (ECM) proteins with various regulatory functions. MCPs are critical regulators of ECM homeostasis and are often found dysregulated in various malignancies. They interact with various proteins like ECM structural proteins, integrins, growth facto...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2016.09.002

    authors: Thakur R,Mishra DP

    更新日期:2016-12-01 00:00:00